Cargando…
Exploiting natural antiviral immunity for the control of pandemics: Lessons from Covid-19
The outbreak of coronavirus disease 2019 (COVID-19), triggered by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), and the disruptive global consequences in terms of mortality and social and economic crises, have taught lessons that may help define strategies to better face future p...
Autores principales: | Aricò, Eleonora, Bracci, Laura, Castiello, Luciano, Urbani, Francesca, Casanova, Jean-Laurent, Belardelli, Filippo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8675148/ https://www.ncbi.nlm.nih.gov/pubmed/34955389 http://dx.doi.org/10.1016/j.cytogfr.2021.12.001 |
Ejemplares similares
-
Are we fully exploiting type I Interferons in today's fight against COVID-19 pandemic?
por: Aricò, Eleonora, et al.
Publicado: (2020) -
Concomitant detection of IFNα signature and activated monocyte/dendritic cell precursors in the peripheral blood of IFNα-treated subjects at early times after repeated local cytokine treatments
por: Aricò, Eleonora, et al.
Publicado: (2011) -
In situ Vaccination by Direct Dendritic Cell Inoculation: The Coming of Age of an Old Idea?
por: Castiello, Luciano, et al.
Publicado: (2019) -
Type I Interferons and Cancer: An Evolving Story Demanding Novel Clinical Applications
por: Aricò, Eleonora, et al.
Publicado: (2019) -
Antiviral and immunomodulatory interferon-beta in high-risk COVID-19 patients: a structured summary of a study protocol for a randomised controlled trial
por: Aricò, Eleonora, et al.
Publicado: (2021)